Report of the Remuneration Committee


The Remuneration Committee meets at least once a year to review the remuneration of the Executive Directors and approve policies for remuneration of other senior executives. The Committee also monitors performance and approves the payment of all performance related bonuses and administers the operation of the share option and share incentive schemes established by the Group.

The Committee is chaired by Susan Lewis and comprises Susan Lewis, John Wheatley, Mark Chambers and Alan Hudson.

The Committee members do not participate in any discussions in which they have an interest.

This Report describes how the Board has voluntarily applied the QCA’s Principles of Good Governance relating to Director’s remuneration. The report also provides the information required to be reported on Directors’ remuneration under AIM Rule 19.


Remuneration policy
The policy is to provide remuneration packages for executive directors which aim to attract and retain high quality executives capable of achieving the Group’s objectives and thereby enhance shareholder value. The performance measurement of the Executive Directors and key members of senior management and the determination of their annual remuneration package is undertaken by the Committee.

The remuneration of the Non-Executive Directors is determined by the Board of Directors.

The following comprises the components of the remuneration of all Executive Directors:

The base salaries of the Executive Directors are set at levels considered to be appropriate when they enter into service agreements with the Group. The base salaries are reviewed by the Remuneration Committee annually and any increases are awarded having regard to performance and salary levels in comparable organisations.

Annual performance related payments
It is the policy of the Company to operate bonus arrangements for the Executive Directors which are performance related, the primary measures being the achievement of financial targets and personal performance.

Benefits in kind
A range of taxable benefits are available to Executive Directors. These benefits primarily comprise the provision of company pension contribution, life assurance and private medical insurance.

Share option schemes
The Company has established approved and unapproved share option schemes, in which the executive directors may participate. Details are set out in note 18 to these financial statements.

Pension arrangements
The group pays a defined contribution to the pension scheme of certain Executive Directors. The individual pension schemes are private and their assets are held separately from those of the Group.

Executive Directors’ contracts
Executive Directors are employed under service contracts requiring a maximum of 12 months’ notice by the company.

Non-Executive Directors’ contracts
The Chairman and the non-executive directors each receive a fee for their services under appointment letters which are for an initial period of 12 months and thereafter terminable by 3 months’ notice from either party. The fee is approved by the Board, mindful of the time commitment and responsibilities of their roles and of current market rates for comparable organisations and appointments. The Non-Executive Directors and the Chairman are reimbursed for travelling and other minor expenses incurred.


Directors’ beneficial interest in the Ordinary shares of the Company (which included those of their families) were as follows:



On 19 November 2019, Growth shares were issued to Alan Hudson, Chief Executive Officer, Paul Wright, Chief Finance Office, Austin Broad, Group Head of Advice and Alex Larvin, Group Head of Risk.

On 24 January 2020, Alan Hudson, Chief Executive Officer, sold 600,000 Ordinary Shares of 10 pence each at a price of 383p per Ordinary Share.

On 2 March 2020 Mark Chambers, Non-Executive Director, purchased 7,309 Ordinary Shares of 10 pence each at a price of 342p per Ordinary Share.

On 23 March 2020 Mark Chambers, Non-Executive Director, purchased 12,601 Ordinary Shares of 10 pence each at a price of 198p per Ordinary Share.

Directors’ shareholdings include any shareholdings of trusts or family members deemed to be connected persons.

The mid-market price of the shares at 31 October 2020 was 298.5p. The range during the year was 427p to 203p.

The Group operates Share Option Plans by which the Executive Directors and other senior executives are able to subscribe
for ordinary shares in the Company. The interests of the directors were as follows:


Any share options that do not meet the performance criteria are cancelled after three years.

The Group Growth Share scheme is administered through AFH Group Limited. Except for the shares created under this scheme which are convertible into share options in AFH Financial Group Plc and those noted above, no Director had any other beneficial interest at the yearend in the shares of any other Group Company.

This report was approved by the Board of Directors on 15 January 2021 and signed on its behalf by:


Susan Lewis
Remuneration Committee
15 January 2021


Annual Report

Please click below to download the full annual report as a PDF file.